Inicio>>Signaling Pathways>> Apoptosis>> Other Apoptosis>>(E)-Flavokawain A

(E)-Flavokawain A (Synonyms: Flavokavain A, 4-methoxy Flavokawain B)

Catalog No.GC34981

(E)-Flavokawain A, una chalcona extraÍda de Kava, tiene efecto anticancerÍgeno. (E)-Flavokawain A induce la apoptosis en células de cÁncer de vejiga mediante la participaciÓn de la vÍa apoptÓtica dependiente de la proteÍna bax y dependiente de las mitocondrias y suprime el crecimiento tumoral en ratones.

Products are for research use only. Not for human use. We do not sell to patients.

(E)-Flavokawain A Chemical Structure

Cas No.: 37951-13-6

Tamaño Precio Disponibilidad Cantidad
1mg Please Inquire Please Inquire
5mg Please Inquire Please Inquire

Tel:(909) 407-4943 Email: sales@glpbio.com


Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

(E)-Flavokawain A, a chalcone extracted from Kava, has anticarcinogenic effect. (E)-Flavokawain A induces apoptosis in bladder cancer cells by involvement of bax protein-dependent and mitochondria-dependent apoptotic pathway and suppresses tumor growth in mice[1].

[1]. Zi X, et al. Flavokawain A, a novel chalcone from kava extract, induces apoptosis in bladder cancer cells by involvement of Bax protein-dependent and mitochondria-dependent apoptotic pathway and suppresses tumor growth in mice. Cancer Res. 2005 Apr 15;65(8):3479-86.

Reseñas

Review for (E)-Flavokawain A

Average Rating: 5 ★★★★★ (Based on Reviews and 28 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for (E)-Flavokawain A

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.